“Tradipitant: A Novel NK-1 Receptor Antagonist for the Management of Motion Sickness- A New Era in Drug Development” (2026) International Journal of Research in Pharmaceutical Sciences and Technology, 9(3). doi:10.33974/xxyc9n51.